Cohen Milstein Survives DQ Bid In Lipitor MDL

Law360, New York (January 17, 2013, 3:23 PM EST) -- Cohen Milstein Sellers & Toll PLLC will remain in multidistrict litigation over Pfizer Inc.'s alleged efforts to keep a generic form of Lipitor off the market after a New Jersey federal judge on Thursday rebuffed Blue Cross Blue Shield of Louisiana's bid to oust the firm.

U.S. District Judge Peter G. Sheridan did not offer reasoning for his decision, which maintains Cohen Milstein as interim co-lead counsel for the end-payor class in the MDL, but ordered the firm to enact steps to separate its work in...
To view the full article, register now.